Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2005-04-21
2009-12-15
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C564S123000, C564S161000
Reexamination Certificate
active
07632866
ABSTRACT:
Compounds, compositions and methods are provided which are useful in the treatment of conditions such as central or peripheral nervous system disorders through the modulation of potassium ion flux through voltage-dependent potassium channels and/or depressing cortical and/or peripheral neuron activity are disclosed. Novel derivatives of N-phenylanthranilic acid are also disclosed.
REFERENCES:
patent: 4016166 (1977-04-01), Noda et al.
patent: 4283532 (1981-08-01), Nohara
patent: 4857645 (1989-08-01), Adachi et al.
patent: 5384330 (1995-01-01), Dieter et al.
patent: 5565483 (1996-10-01), Hewawasam et al.
patent: 6117900 (2000-09-01), Rundfeldt et al.
patent: 6291442 (2001-09-01), Yellen
patent: 6291523 (2001-09-01), Fujimoto et al.
patent: 6348486 (2002-02-01), Argentieri et al.
patent: 6355680 (2002-03-01), Cohen
patent: 6472165 (2002-10-01), Rundfeldt et al.
patent: 6589986 (2003-07-01), Bowlby et al.
patent: 6593349 (2003-07-01), McNaughton-Smith et al.
patent: 2003/0055095 (2003-03-01), Baragi et al.
patent: 0554543 (1996-02-01), None
patent: WO 98/20864 (1998-05-01), None
patent: WO 00/34248 (2000-06-01), None
patent: WO-2000-061541 (2000-10-01), None
patent: WO/2000/061541 (2000-10-01), None
patent: WO 01/19406 (2001-03-01), None
patent: WO-2002-000167 (2002-01-01), None
patent: WO 02/00167 (2002-03-01), None
patent: WO 02/36121 (2002-05-01), None
patent: WO 2004/035037 (2004-04-01), None
Biervert et al., Science, vol. 279, Jan. 16, 1998 (provided in IDS).
Patini et al., Chem. Rev. 1996, 96, 3147-3176.
Liu, et al., Clin. Exp. Pharm. Phys, vol. 29, No. 4, 2002, pp. 305-311.
Peretz et al. “Meclofenamic Acid and Diclofenac, Novel Templates of KCNQ2/Q3 Potassium Channel Openers, Depress Cortical Neuron Activity and Exhibit Anticonvulsant Properties”, Molecular Pharmacology, 67(4): 1-14, 2005.
Pedarzani et al. “Control of Electrical Activity in Central Neurons by Modulating the Gating of Small Conductance Ca2+-Activated K+ Channels”, The Journal of Biological Chemistry, 276(13): 9762-9769, 2001. Abstract.
Baranauskas et al. “Kv3.4 Subunits Enhance the Repolarizing Efficiency of Kv3.1 Channels in Fast-Spiking Neurons”, Nature Neuroscience, 6(3): 258-266, 2003.
Biervert et al. “A Potassium Channel Mutation in Neonatal Human Epilepsy”, Science, 279: 403-406, 1998.
Butler et al. “Mslo, A Complex Mouse Gene Encoding “Maxi” Calcium-Activated Potassium Channels”, Science, 261(5118): 221-225, 1993.
Du et al. “Development Expression and Functional Characterization of the Potassium-Channel Subunit Kv3.1b in Parvalbumin-Containig Interneurons of the Hippocampus”, The Journal of Neuroscience, 16(2): 506-518, 1996.
Heinemann et al. “Functional Characterization of Kv Channel β-Subunits From Rat Brain”, Journal of Physiology, 493(3): 625-633, 1996.
Jahnel et al. “Dual Expression of Mouse and Rat VRL-1 in the Dorsal Root Ganglion Derived Cell Line F-11 and Biochemical Analysis of VRL-1 After Heterologous Expression”, European Journal of Biochemistry, 270: 4264-4271, 2003.
Joiner et al. “Formation of Intermediate-Conductance Calcium-Activated Potassium Channels by Interaction of Slack and Slo Subunits”, Nature Neuroscience, 1: 462-469, 1998.
Jurman et al. “Visual Identification of Individual Transfected Cells for Electrophsyiology Uding Antibody-Coated Beads”, Biotechniques, 17(5): 876-881, 1994. Abstract.
Kananura et al. “The New Voltage Gated Potassium Channel KCNQ5 and Neonatal Convulsions”, Genetics of Nervous System Diseases, 11(9): 2063-2067, 2000.
Kubisch et al. “KCNQ4, A Novel Potassium Channel Expressed in Sensory Outer Hair Cells, Is Mutated in Dominant Deafness”, Cell, 96: 437-446, 1999.
Leppert et al. “Benign Familial Neonatal Convulsions Linked to Genetic Markers on Chromosome 20”, Nature, 337(6208): 647-648, 1989. Abstract.
Main et al. “Modulation of KCNQ2/3 Potassium Channels by the Novels Anticonvulsant Retigabine”, Molecular Pharmacology, 58: 253-262, 2000.
Meera et al. “Large Conductance Voltage- and Calcium-Dependent K+ Channel, A Distinct Member of Voltage-Dependent Ion Channels With Seven N-Terminal Transmembrane Segments (S0-S6), An Extracellular N Terminus, and An Intracellular (S9-S10) C Terminus”, Proc. Natl. Acad. Sci. USA, 94: 14066-14071, 1997.
Passmore et al. “KCNQ/M Currents in Sensory Neurons: Significance for Pain Therapy”, The Journal of Neuroscience, 23(18): 7227-7236, 2003.
Sanguinetti et al. “Coassembly of k Sub V LQT1 and MinK (lsK) Proteins to Form Cardiac I Sub Ks Potassium Channel”, Nature, 384(6604): 80-83, 1996.
Schreiber et al. “Slo3, A Novel PH-Sensitive K+ Channel From Mammalian Spermocytes”, The Journal of Biological Chemistry, 273(6): 3509-3516, 1998.
Shah et al. “Molecular Correlates of the M-Current in Cultured Rat Hippocampal Neurons”, The Journal of Physiology, 544: 29-37, 2002.
Shi et al. “β Subunits Promote K+ Channel Surface Expression Through Effects Early in Biosynthesis”, Neuron, 16: 843-852, 1996.
Syme et al. “Pharmacological Activation of Cloned Intermediate- and Small-Conductance Ca+ -Activated K+ Channels”, American Journal of Physiology and Cell Physiology, 278: C570-C581, 2000.
Tatulian et al. “Activation of Expressed KCNQ Potassium Currents and Native Neuronal M-Type Potassium Currents by the Anti-Convulsant Drug Retigabine”, The Journal of Neuroscience, 21(15): 5535-5545, 2001.
Wang et al. “KCNQ2 and KCNQ3 Potassium Channel Subunits: Molecular Correlates of the M-Channel”, Science, 282: 1890-1893, 1998.
Wei et al. “Eight Potassium Channel Families Revealed by the C. Elegans Genome Project”, Neuropharmacology, 35(7): 805-829, 1996.
Wickenden et al. “Characterization of KCNQ5/Q3 Potassium Channels Expressed in Mammalian Cells”, British Journal of Pharmacology, 132: 381-384, 2001.
Yang et al. “Functional Expression of Two KvLQT1-Related Potassium Channels Responsible for An Inherited Idiopathic Epilepsy”, The Journal of Biological Chemistry, 273(31): 19419-19423, 1998.
Yue et al. “KCNQ/M Channels Control Spike Afterdepolarization and Burst Generation in Hippocampal Neurons”, The Journal of Neuroscience, 24(19): 4614-4624, 2004.
International Search Report Dated Mar. 6, 2009 From the International Searching Authority Re.: Application No. PCT/IL2008/001257.
Written Opinion Dated Mar. 6, 2009 From the International Searching Authority Re.: Application No. PCT/IL2008/001257.
Beilstein Database Beilstein, Beilstein Institute for Organic Chemistry, XP002516450, Database Accession No. Beilstein Registry No. 3410361, Apr. 2008. Abstract. & Levi et al., Journal of the Chemical Society, pp. 1490, 1493, 1933.
Trishin et al. “Reaction of Pentafluorophenyl(Diphenyl)Phosphine With Nitrilimines”, Russian Journal of General Chemistry, XP002516449, 71(3): 471- 475, 2001.
Vercouillie et al. “Synthesis and In Vitro Evaluation of Novel Derivatives of Diphenylsulfide as Serotonin Transporter Ligands”, Bioorganic & Medicinal Chemistry Letters, XP025106339, 16(5): 1297-1300, Mar. 1, 2006. p.1297, Abstract, p.1298, Scheme 1, Compounds 5a-9a, 5b-9b.
Wilson et al. “Hypoxia-Selective antitumor Agents. 1. Relationships Between Structure, Redox Properties and Hypoxia-Selective Cytotoxicity for 4-Substituted Derivatives of Nitracrine”, Journal of Medicinal Chemistry, XP001016258, 32: 23-30, Jan. 1, 1989. p.24, ‘Scheme I’, Compounds III, V.
Attali Bernard
Peretz Asher
Chung Susannah
Ramot At Tel Aviv University
Shameem Golam M. M.
LandOfFree
Derivatives of N-phenylanthranilic acid and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of N-phenylanthranilic acid and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of N-phenylanthranilic acid and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4094231